New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk
NNC2215, a newly developed glucose-sensitive insulin, auto-adjusts its activity based on blood sugar levels, offering improved glycemic control and reducing the risk of hypoglycemia in diabetes patients. Study: Glucose-sensitive insulin with attenuation of hypoglycaemia. Image Credit: AYO Production/Shutterstock.com In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin […]
